STAGE IV RECTAL CANCER AJCC V8
Clinical trials for STAGE IV RECTAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV RECTAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV RECTAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat colon cancer patients
Disease control OngoingThis early-stage trial is testing whether combining existing cancer drugs with a new experimental drug (LY3214996) can help control advanced colorectal cancer that has stopped responding to standard treatments. The study aims to find safe doses and see if these combinations can s…
Matched conditions: STAGE IV RECTAL CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New Two-Drug attack on Tough-to-Treat colon cancer
Disease control OngoingThis study is testing a new two-drug combination for people with advanced colorectal cancer that has spread and is no longer responding to standard chemotherapy. The trial combines an experimental pill called SX-682, which aims to block tumor growth, with an existing immunotherap…
Matched conditions: STAGE IV RECTAL CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Can an immunotherapy boost stop tough colon cancer?
Disease control OngoingThis study is for people with advanced colorectal cancer that has spread or cannot be removed by surgery and has a specific BRAF gene mutation. It tests if adding the immunotherapy drug nivolumab to two standard targeted drugs works better to control the cancer and stop it from g…
Matched conditions: STAGE IV RECTAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Four-Pronged attack on Tough-to-Treat colon cancer
Disease control OngoingThis study is testing a new combination of four drugs for people with a common type of advanced colorectal cancer that has spread. The goal is to find the safest and most effective dose and see if this four-drug approach can help control the cancer. It combines standard chemother…
Matched conditions: STAGE IV RECTAL CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Tracking life after rectal cancer: how surgery affects daily living
Knowledge-focused TerminatedThis study aims to understand how rectal cancer surgery affects patients' quality of life over time. Researchers will follow 430 patients for up to 5 years after their surgery, asking them to complete questionnaires about their daily experiences. The goal is to gather information…
Matched conditions: STAGE IV RECTAL CANCER AJCC V8
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
Blood holds clues to rectal Cancer's future
Knowledge-focused OngoingThis study aims to learn if tiny pieces of cancer floating in the blood can help doctors understand how rectal cancer responds to treatment. Researchers are collecting blood samples from 341 patients with rectal cancer and some healthy volunteers to track these 'circulating tumor…
Matched conditions: STAGE IV RECTAL CANCER AJCC V8
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC